COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 4, 2022

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions
SARS-CoV-2 InfectionCOVID-19
Interventions
DEVICE

iCura COVID-19 Antigen Rapid Home Test

Candidate Ag self-test kit anterior nasal specimen collection and testing will be done under the supervision of qualified site personnel in person. Comparator NP samples shall be collected at least 15 minutes prior to Ag samples with at least 15 minutes between nasal collections including collections that may occur prior to study enrollment. Comparator samples will be collected first by qualified personnel at a study site or physician's office using an FDA authorized nasopharyngeal swab collection kit and SARS-CoV-2 molecular assay.

DIAGNOSTIC_TEST

RT-PCR Test

High sensitivity RT-PCR COVID-19 Test

Trial Locations (2)

37919

EDP Biotech, Knoxville

92703

Paragon, Anaheim

Sponsors
All Listed Sponsors
collaborator

Paragon Rx Clinical, Inc.

UNKNOWN

collaborator

iCura Diagnostics, LLC

UNKNOWN

lead

New Day Diagnostics

NETWORK

NCT05555030 - COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation | Biotech Hunter | Biotech Hunter